European Alliance for Access to Safe Medicines
EAASM
The EAASM will strive to ensure that patients within the EU are aware of falsified and substandard medicines and unsafe medical practices and that national governments have put in place mechanisms to protect the population.
Lobbying Activity
Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)
30 May 2022 · Nano-medicines and EU regulatory Framework.
Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC
26 Apr 2021